Wird geladen...
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis
BACKGROUND: Treatment with recombinant human erythropoietin (rHuEPO) in dialysis patients has been shown to be highly effective in terms of correcting anaemia and improving quality of life. There is debate concerning the benefits of rHuEPO use in predialysis patients which may accelerate the deterio...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2016
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144724/ https://ncbi.nlm.nih.gov/pubmed/26790135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003266.pub3 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|